Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neuroblastoma 1 Neoplasms 1 Lymphoma, Large B-Cell, Diffuse 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1

Interventions

Cyclophosphamide 32 Filgrastim 18 Irinotecan 15 Topotecan 14 Temozolomide 13 Vincristine 12 Peripheral Blood Stem Cell Transplantation 12 Granulocyte Colony-Stimulating Factor 12 Etoposide 12 Melphalan 11 fludarabine 10 Carboplatin 9 dinutuximab 8 Isotretinoin 8 Interleukin-2 8 Busulfan 8 humanized 3F8 anti-GD2 monoclonal antibody 7 aldesleukin 7 Doxorubicin 7 3-Iodobenzylguanidine 7 sargramostim 6 fludarabine phosphate 6 Vorinostat 6 Zoledronic Acid 5 Stem Cell Transplantation 5 Cisplatin 5 etoposide phosphate 4 Ipilimumab 4 Drug Therapy 4 ribociclib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Neuroblastoma × Antibodies × Clear all

NCT02914405 2026-04-28

MiniVan

University Hospital Southampton NHS Foundation Trust

Phase 1 Active not recruiting

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡